Psychiatric comorbidity: Prevalence in methadone maintenance treatment
Psychiatric comorbidity: Prevalence in methadone maintenance treatment
复制标题
DOI：
10.3109/00952999609001647
复制
发表时间：
1996-01-01
影响因子：
2.7
通讯作者：
Haas, N
中科院分区：
文献类型：
--
作者：
Milby, JB;Sims, MK;Haas, N
本研究探讨了三个随访样本的阿片类药物成瘾者美沙酮维持治疗的DSM-III-R焦虑和情感障碍的患病率。至少有一种焦虑症被诊断为总样本的55%。情感障碍占58%。在36%的样本中，至少有一种焦虑症与至少一种情感障碍共存。研究表明，在这个样本中，阿片类药物成瘾通常与其他共病精神病理学有关。这表明需要对进入成瘾治疗的阿片类成瘾者进行全面的精神病理学评估，特别是对焦虑和情感障碍的评估。它还表明，除了对药物滥用障碍的药物咨询外，还需要对诊断出的精神障碍进行治疗。
This study examines prevalence rates for DSM-III-R anxiety and affective disorders in three follow-up samples of opioid addicts who were treated with methadone maintenance. At least one anxiety disorder was diagnosed in 55% of the total sample. Affective disorders were found in 58%. At least one anxiety disorder coexisted with at least one affective disorder in 36% of the sample. The research demonstrates that opiate addiction in this sample is most often associated with other comorbid psychopathology. it suggests a need for thorough assessment for general psychopathology in opioid addicts entering addiction treatment, especially assessment for anxiety and affective disorders. It also suggests the need for treatment that focuses on diagnosed mental disorders in addition to drug counseling for the substance abuse disorder.